We reply within one business day
Applications · Format guide
Whole leaf powder, standardised dry extract and finished capsules are three different procurement objects. Confusing them on a PO means a COA that does not match your formulation spec and potential regulatory problems at clearance.
Three objects
Whole leaf powder is the milled dried leaf matrix. Standardised extract is solvent-processed, spray-dried concentrate at an x:1 ratio with a marker assay. Finished capsules/tablets are a manufactured end-format that can contain either — but are themselves not an ingredient.
Milled dried leaf
Mature leaves shade-dried 2–3 d (<55 °C), hammer-milled and sieved. Full fibre, full colour, full mineral co-factors. COA must declare “moringa oleifera leaf powder”.
Solvent + concentrate
Same leaf, plus solvent extraction (water / hydro-ethanolic etc.) then spray-drying. Assayed against a marker (total polyphenols, flavonoids, isothiocyanates) at a declared ratio like 5:1 / 10:1 / 20:1.
End-format
Encapsulated or compressed dosage form — may contain leaf powder or extract plus excipients. You are buying a GMP-manufactured article, not a raw ingredient.
If a supplier writes “moringa extract” on what is actually milled leaf, that is a labelling error to catch before your FDA facility registration or import file is on the line.
Leaf powder — spec
Seven categories. Each maps to a quality risk you can actually enforce.
Mesh figures are general ASTM/EU sieve engineering tables — not moringa-validated. Always specify microns too. The re-absorption risk is severe at finer grinds: the powder may need a second drying pass and a sealed pack with desiccant. Fibre typically 20–30% dry weight — an asset in food, a limiting factor in a capsule dose.
Extract — COA wajib
A genuine standardised extract COA must carry three things. Without any one of them, you have no way to know what you bought — it may be leaf powder at an extract price.
Head-to-head
Same leaf, different downstream — and a different line on your import file.
No “extract” without ratio + marker + assay method. That triad is the buyer’s minimum proof it is not leaf powder repriced.
End-format
Capsules/tablets are not an ingredient — they are a manufactured article that happens to contain an ingredient. The same factory can encapsulate leaf powder in one SKU and standardised extract in another at an entirely different potency. Never assume which is inside from the words “moringa capsules” alone.
Which format fits which application
Fibre helps food; it limits capsule dose. That is where extract earns its price.
Fibre is an asset; flavour and colour matter; protein/mineral co-factors sell.
Note
80–100 mesh · bright green · low moisture.
Full leaf matrix is the positioning — lower cost per kg, larger fill weight needed.
Note
100 mesh · micro panel primary.
Fibre limits dose; concentrated marker allows smaller capsule to hit actives target.
Note
Declared x:1 + marker assay + residual solvent · colour expected tan.
Texture and colour matter; actives concentration via solvent extract is a different brief.
Note
200 mesh+ with d50/d90 · confirm “leaf-only” vs stem.
If you buy leaf powder to repack as extract potency — or vice versa — the COA and label mismatch is a compliance problem. Set the declaration on the PO.
Sourcing risk
Without ratio + marker + assay method, “moringa extract” on an invoice is not proven. Brands making potency claims on an undeclared powder have both a procurement and a regulatory exposure. This is a direct sourcing risk — particularly for potency-positioned supplement claims.
Format FAQ
No. Leaf powder is the milled dried leaf matrix — fibre, colour, minerals intact. Standardised dry extract is solvent-extracted and spray-dried concentrate at a declared ratio (5:1, 10:1, 20:1) and assayed against a marker (total polyphenols, flavonoids, or isothiocyanates). They look similar but belong on different COAs and different import declarations. Confusing them is a procurement and regulatory error.
The extract COA must state three things: (1) “standardised dry extract” — not “leaf powder”, (2) the extraction ratio (x:1), and (3) the standardisation marker and assay result with method and limit (e.g. “≥10% total polyphenols by UV-Vis”). Without that triad — plus residual-solvent where applicable — you have no way to know what you bought. It may be leaf powder at an extract price. Require the declaration on the COA to match the PO verbatim.
That is an end-format decision, not a raw-material debate. Capsules are a manufactured article that can contain either leaf powder or extract plus excipients; bulk powder is the ingredient you would encapsulate yourself. Capsules save repack but add GMP manufacturing and per-bottle MOQ; bulk powder gives you control over fill, count and assay. India B2B listings show capsule MOQs around ~100 bottles; Indonesian capsule-finish capability is less documented and needs direct confirmation. Decide by dose target, regulatory path, and who holds the GMP agreement.
The question inverts. Extract and leaf powder are not mesh grades — they are different processes. Leaf-powder mesh (60/80/100/200 — general ASTM engineering figures) governs powder flow and mouthfeel; extract fineness is a spray-dry concentrate property governed by the extraction and drying, not a sieve tier. If your spec says “100 mesh leaf powder” you are buying milled leaf at ~150 µm; if it says “10:1 extract std. to 10% polyphenols” the relevant number is the ratio and marker, not the sieve. Do not put a mesh spec on an extract PO.
Related guides
Format is one axis — the guides below define the spec, process and commercial terms that travel with it.
Brief the desk
Tell us whether you need leaf powder or standardised extract (and at which ratio/marker), or a finished capsule run. We route to the processor line that actually runs that format.
We reply within one business day
Handled by BD Juara Holding Group
